Valentina Folgiero

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Pseudomonas Aeruginosa

Biofilm Formation

Top Venues

Journal of experimental & clinical cancer research : CR

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

M Caforio, S Iacovelli, C Quintarelli, F Locatelli, Valentina Folgiero
GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
M Caforio, S Iacovelli, C Quintarelli, F Locatelli, Valentina Folgiero
GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
M Caforio, S Iacovelli, C Quintarelli, F Locatelli, Valentina Folgiero
GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
M Caforio, S Iacovelli, C Quintarelli, F Locatelli, Valentina Folgiero
GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Matteo Caforio, Cristina Sorino, Ignazio Caruana, Gerrit Weber, Antonio Camera, Loredana Cifaldi, Biagio De Angelis, Francesca Del Bufalo, Alessia Vitale, Bianca Maria Goffredo, Rita De Vito, Doriana Fruci, Concetta Quintarelli, Maurizio Fanciulli, Franco Locatelli, Valentina Folgiero
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape. Journal for immunotherapy of cancer 9 (3) (2021)
Matteo Caforio, Cristina Sorino, Stefano Iacovelli, Maurizio Fanciulli, Franco Locatelli, Valentina Folgiero
Recent advances in searching c-Myc transcriptional cofactors during tumorigenesis. Journal of experimental & clinical cancer research : CR 37 (1) (2018)